<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><label>Table 2.</label><caption><title>Comparison of TcMAC21 and other mouse models of DS.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Issues</th><th>TcMAC21</th><th>Tc1</th><th>Ts65Dn</th><th>Ts1Cje</th><th>Dp(16)1Yey/+ or Dp1Tyb</th><th>Dp(10)1Yey/+; Dp(16)1Yey/+; Dp(17)1Yey/+</th></tr></thead><tbody><tr><td>Mosaicism</td><td>No</td><td>Yes</td><td>No</td><td>No</td><td>No</td><td>No</td></tr><tr><td>Freely segregating chromosome</td><td>Yes</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>No</td></tr><tr><td>Trisomic HSA21q PCG/orthologs <break/>(% of 213 HSA21q)</td><td>199 <break/>(93.4%)</td><td>158 <break/>(74.2%)</td><td>110 <break/>(51.6%)</td><td>68 <break/>(31.9%)</td><td>122 <break/>(57.3%)</td><td>180 (40;122;18) <break/>(84.5%)</td></tr><tr><td>Trisomic HSA21q PCG/orthologs, excluding KRTAPs</td><td>150</td><td>109</td><td>92</td><td>68</td><td>104</td><td>160</td></tr><tr><td>* Trisomic mouse PCGs with no human ortholog</td><td>0</td><td>0</td><td>7</td><td>7</td><td>10</td><td>12</td></tr><tr><td>&#8224; Trisomic or monosomic PCGs that are not HSA21 orthologs</td><td>0</td><td>0</td><td>Trisomic <break/>~44 MMU17</td><td>Monosomic&#160;~&#160;7 <break/>MMU12</td><td>0</td><td>0</td></tr></tbody></table><table-wrap-foot><fn><p>*Refer to data file S1A for the name and location of each mouse PCG conserved with Hsa21 (MMU10, 16, 17). Gene annotation is based on &#8216;GRCh38, P12&#8217; and &#8216;GRCm.P6&#8217;.</p><p>&#8224;The reference of the translocation breakpoints of Ts65Dn and Ts1Cje is &#8220;Duchon A, Raveau M, Chevalier C, Nalesso V, Sharp AJ, Herault Y. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome. 2011;22(11, 12):674&#8211;684.&#8217; The number of genes is based on &#8216;GRCm.P6&#8217;.</p></fn></table-wrap-foot></table-wrap>